Hemodynamic Comparison of Peripheral and Central VA ECMO.
- Conditions
- Cardiac ArrestHemodynamics InstabilityExtracorporeal Circulation; ComplicationsShock, Cardiogenic
- Interventions
- Procedure: Veno-arterial extracorporeal membrane oxygenation
- Registration Number
- NCT05669183
- Brief Summary
The goal of this clinical trial is to monitor hemodynamic differences between central veno-arterial extracorporeal membrane oxygenation (VA ECMO) and peripheral VA ECMO. The main question it aims to answer is:
* Efficacy of the different cannulation strategies for the establishment of for VA-ECMO circulation on hemodynamics and organ perfusion.
Participants require VA ECMO support, will be divided into two groups in an intention-to-treat analysis: central artery cannulation and peripheral artery cannulation.
Researchers will analyze different cannulation strategies for VA-ECMO and identify potential advantages and disadvantages for two groups of VA-ECMO.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 136
- Ageā„18 years
- Participants with cardiogenic shock
- Obtaining informed consent from participants or their affiliated beneficiaries
- Irreversible heart failure
- Contraindications to anticoagulation therapy
- Uncontrolled bleeding
- Irreversible neurological pathology
- Participants limited to extracorporeal cardiopulmonary resuscitation
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Central VA ECMO Veno-arterial extracorporeal membrane oxygenation Axillary artery cannulation for veno-arterial extracorporeal membraneous oxygenation (VA ECMO) Peripheral VA ECMO Veno-arterial extracorporeal membrane oxygenation Femoral artery cannulation for veno-arterial extracorporeal membraneous oxygenation (VA ECMO)
- Primary Outcome Measures
Name Time Method Left ventricular end-diastolic volume (ml) Through VA ECMO support completion, an average of 1 week echocardiography
Mitral valve area(cm2) Through VA ECMO support completion, an average of 1 week echocardiography
Oxygen saturation-no. (%) Through VA ECMO support completion, an average of 1 week Blood gas analysis
Left ventricular End-systolic volume (ml) Through VA ECMO support completion, an average of 1 week echocardiography
Stroke volume (ml) Through VA ECMO support completion, an average of 1 week echocardiography
- Secondary Outcome Measures
Name Time Method Duration of ICU stay Through study completion, up to 2 years Intensive care unit length of stay
Duration of hospital stay Through study completion, up to 2 years Length of hospital stay
VA ECMO duration Through VA ECMO support, an average of 1 week Length of VA ECMO support
Cannulation-related complications Through study completion, up to 2 years Cannulation-related complications include bleeding, limb ischemia, revision of cannulation site, wound complications. Limb ischemia is defined as ischemia requiring any surgical procedure, including revision of the arterial/distal perfusion cannula, fasciotomy for compartment syndrome, gangrene, or amputation. Wound complication is defined as infection or requirement of an additional surgical intervention, such as arterial repair, washout with or without vacuum-assisted closure, and muscle flap closure.
Rate of successful weaning from VA ECMO Through study completion, up to 2 years Weaning success is defined as survival after complete removal of the extracorporeal circuit without requirement for further mechanical support or heart transplant.
Trial Locations
- Locations (1)
First Affiliated Hospital of Xi'an Jiaotong University
šØš³Xi'an, Shaanxi, China